To determine the baseline serum levels of LAMP-2 in PBC, we measured the LAMP-2 in serum samples before treatment collected from PBC patients and controls by Enzyme-linked immunosorbent assay (ELISA) (Fig. 1a). Here, LAMP2 is linked to primary biliary cholangitis.